Merck unit files DJ action involving pneumococcal vaccine patents
Clients Merck & Co., Inc.
Jones Day is representing Merck Sharp & Dohme Corp. in an action in Delaware district court against Wyeth, LLC seeking declaratory judgment of invalidity and non-infringement of U.S. patent Nos. 8,895,024; 8,808,708 and 9,399,060 relating to a new 15-valent pneumococcal conjugate vaccine, known as V114, for the prevention of invasive pneumococcal disease in adults 18 years of age and older.
Merck Sharp & Dohme Corp. v. Wyeth LLC, No. 1-21-cv-00024 (D. Del.)